Orion Oyj (OTCMKTS:ORINY) Increases Dividend to $0.51 Per Share

Orion Oyj (OTCMKTS:ORINYGet Rating) announced a dividend on Friday, March 17th, investing.com reports. Stockholders of record on Friday, March 24th will be given a dividend of 0.505 per share on Monday, April 17th. This represents a dividend yield of 1.92%. The ex-dividend date is Thursday, March 23rd. This is a boost from Orion Oyj’s previous dividend of $0.50.

Orion Oyj Price Performance

Shares of Orion Oyj stock opened at $26.26 on Friday. The stock’s fifty day moving average is $26.55 and its 200-day moving average is $23.60. The firm has a market capitalization of $7.41 billion, a PE ratio of 32.83 and a beta of 0.30. The company has a quick ratio of 1.31, a current ratio of 2.65 and a debt-to-equity ratio of 0.27. Orion Oyj has a 12-month low of $20.11 and a 12-month high of $28.05.

Orion Oyj (OTCMKTS:ORINYGet Rating) last announced its earnings results on Thursday, February 9th. The company reported $0.12 earnings per share (EPS) for the quarter. The company had revenue of $300.71 million for the quarter. Orion Oyj had a return on equity of 27.56% and a net margin of 18.72%.

About Orion Oyj

(Get Rating)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease.

Featured Articles

Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.